Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Paromomycin sulphate

EU orphan designation number: EU/3/05/271
Active ingredient: Paromomycin sulphate
Indication: Treatment of visceral leishmaniasis
Sponsor: Sestria Ltd
88 High Street North, Stewkley, Bedfordshire LU7 0EW, United Kingdom

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
14/04/2005 Centralised Orphan - Designation EMEA/OD/086/04 (2005)1203 of 11/04/2005
17/10/2006 Other procedure EMEA/OD/086/04
30/11/2009 Centralised Orphan - Transfer of orphan designation EMEA/OD/086/04/T/01 (2009)9348 of 20/11/2009
11/03/2011 Centralised Orphan - Removal of orphan designation from Community Register